PLAINSBORO, N.J. and AMSTERDAM, The Netherlands , Sept. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris®
Upper Extremity Constant Currency Growth of 11.9% Led by the Aequalis Ascend™ Flex AMSTERDAM, Netherlands , Aug. 5, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its
AMSTERDAM, The Netherlands , July 29, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the second quarter ended June 28, 2015 after the
Transaction Expected to Close in Third Quarter of 2015, Subject to Receipt of Clearance by FTC MEMPHIS, Tenn. and AMSTERDAM, The Netherlands , June 18, 2015 (GLOBE NEWSWIRE) -- Wright Medical Group, Inc. (Nasdaq:WMGI) and Tornier N.V. (Nasdaq:TRNX) today announced that all proposals related to the
Upper extremity constant currency growth of 14.0% led by Aequalis Ascend® Flex™ Total extremities constant currency revenue growth of 9.2% Adjusted gross margin increased by 220 basis points to 77.3% AMSTERDAM, The Netherlands , May 5, 2015 (GLOBE NEWSWIRE) -- Tornier N.V.
AMSTERDAM, The Netherlands, April 15, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the first quarter ended March 29, 2015 after the
New Class of Ultra Short-Stem Total Shoulder Arthroplasty Will Increase Access to Treatment for Patients With Compromised Shoulder Function and Severe Pain AMSTERDAM, The Netherlands , March 10, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on
Fourth quarter revenue increased 14.1% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 22.1% led by Aequalis Ascend Flex Full year adjusted gross margin increased by 180 basis points to 76.0% AMSTERDAM, The Netherlands , Feb.
AMSTERDAM, The Netherlands , Feb. 4, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the fourth quarter and full year ended December 28,
Fourth Quarter Revenue Increases 11.3% to $92.8 Million Full Year 2014 Revenue of $345.4 Million Represents 11.1% Growth Fourth Quarter Extremities Revenue Grew 16.0% in Constant Currency Over Prior Year AMSTERDAM, The Netherlands , Jan. 12, 2015 (GLOBE NEWSWIRE) -- Tornier N.V.
November 19, 2014 AMSTERDAM, The Netherlands , Nov. 19, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive
AMSTERDAM, The Netherlands , Nov. 19, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
Revenue increased 14.0% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 20.0% led by Aequalis Ascend Flex Entered into definitive merger agreement with Wright Medical Group on October 27 to create premier high-growth extremities-biologics company
October 27, 2014 Combination Will Offer Comprehensive Upper and Lower Extremity Product Portfolio and Broad Global Reach Further Accelerates Growth Opportunities in Three of the Fastest Growing Areas in Orthopaedics Adds Significant Scale and Scope to Provide Accelerated Path to Profitability and
AMSTERDAM, The Netherlands , Oct. 27, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced revenue for the third quarter ended September 28, 2014 .
AMSTERDAM, The Netherlands , Oct. 22, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter ended September 28,
Revenue increased 9.5% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 11.4% led by Aequalis Ascend Flex Increases full year revenue and EBITDA guidance AMSTERDAM, The Netherlands , Aug. 7, 2014 (GLOBE NEWSWIRE) -- Tornier N.V.
AMSTERDAM, The Netherlands , July 10, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter ended June 29, 2014
AMSTERDAM, The Netherlands , May 8, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
Revenue increased 6.8% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 9.9% led by Aequalis Ascend Flex U.S. distribution transition progressing from sales force alignment to optimization AMSTERDAM, The Netherlands , May 6, 2014 (GLOBE NEWSWIRE) --
AMSTERDAM, The Netherlands , April 16, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 30, 2014
AMSTERDAM, Netherlands , Feb. 24, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the commencement of a proposed underwritten public offering of 5,125,000 ordinary
Phase 1 of U.S. distribution channel transition complete; Phase 2 underway, with focus on sales force optimization and training New product launches and pipeline on track, led by Aequalis Ascend Flex adoption and expected second quarter launch of Aequalis Reversed in Japan AMSTERDAM, The
AMSTERDAM, The Netherlands , Feb. 10, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
AMSTERDAM, The Netherlands , Feb. 4, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended
Fourth Quarter Revenue Expected to Increase by 5.1% to 6.3% to $83 to $84 Million AMSTERDAM, The Netherlands , Jan. 13, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today
AMSTERDAM, The Netherlands , Dec. 30, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
AMSTERDAM , Nov. 20, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn McCormick , the
U.S. distribution channel transition accelerates with agreements covering 61% of U.S. revenue Non-GAAP gross margin improved to 74.2% Aequalis Ascend Flex ™ launch tracking to plan; over 120 trained surgeon users AMSTERDAM, The Netherlands , Nov. 5, 2013 (GLOBE NEWSWIRE) -- Tornier N.V.
AMSTERDAM , Oct. 10, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter ended September 29, 2013 after the
Achieves Double-Digit Upper Extremity Product Category Growth Improves Non-GAAP Gross Margin Sequentially and Quarter over Quarter to 73.9% Expands OrthoHelix Product Line Reach with First International Sale AMSTERDAM , Aug. 6, 2013 (GLOBE NEWSWIRE) -- Tornier N.V.
July 15, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter ended June 30, 2013 after the market
May 15, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the closing of the previously announced underwritten public offering of 8.05 million ordinary shares
May 9, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the pricing of a previously announced underwritten registered public offering of 7.0 million ordinary
May 7, 2013 Reiterates Revenue and Non-GAAP Adjusted EBITDA Outlook for 2013 Non-GAAP Adjusted Gross Margin Expands 200 Basis Points Year over Year, Excluding Acquisition Related Costs AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing
Maay 7, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it has commenced an underwritten public offering of 7.0 million ordinary shares.
April 26, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn McCormick , the
April 3, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 31, 2013 after the market
February 21, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H.
February 21, 2013 OrthoHelix Acquisition Closed and Integration Proceeding Smoothly Adjusted EBITDA Margin Improves for both Fourth Quarter and Full Year AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
February 11, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Interim President and Chief Executive Officer, and Shawn
January 22, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 31,
January 7, 2013 Full Financial Results Available on February 21, 2013; Company to Present at J.P. Morgan Healthcare Conference on January 7, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
December 18, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Interim President and Chief Executive Officer, and Shawn
November 15, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Interim President and Chief Executive Officer, and Shawn
November 12, 2012 Medical Device Industry Veteran Kevin C. O'Boyle Named Interim Vice Chairman AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced the appointment of
November 5, 2012 Shoulder Products Drive Extremities Constant Currency Growth of 7% OrthoHelix Acquisition Provides Significant New Growth Opportunity AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
November 1, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Chief Operating Officer, and Shawn McCormick , the Company's
October 17, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter and nine months ended September 30,
August 24, 2012 Acquisition Is Expected to More Than Double Tornier's Lower Extremity Revenue Transaction Will Bring Innovative Technologies, High Growth, and Strong Gross Margins AMSTERDAM & MEDINA, Ohio --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on
August 7, 2012 Shoulder Products Drive Extremities Constant Currency Growth of 8% Adjusted EBITDA Margin Improves Year Over Year for 4th Consecutive Quarter AMSTERDAM, The Netherlands --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical
July 18, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it has appointed Shawn T McCormick as Chief Financial Officer, effective as of September 4,
July 17, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter and six months ended June 30, 2012
June 20, 2012 Award Recognizes Entrepreneurial Excellence in Healthcare Category MINNEAPOLIS --(BUSINESS WIRE)-- Tornier, Inc. , the U.S. operating subsidiary of Tornier NV (NASDAQ: TRNX) announced that Douglas W. Kohrs , President and CEO of Tornier , a global medical device company focused on
June 12, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Chief Operating Officer, and Carmen Diersen , the Company's Chief
May 8, 2012 Strong International Sales Drive Global Extremities Constant Currency Growth of 11.4% AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial
May 1, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs , the Company's President and Chief Executive Officer, and Carmen Diersen , the
April 13, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it plans to consolidate its facilities to drive operational productivity and to reduce annual
April 10, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the three months ended April 1, 2012 after the market
February 23, 2012 Fourth Quarter Sales and Adjusted EBITDA Exceeded Guidance 2012 Outlook Includes Double-Digit Constant Currency Extremities Growth AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
February 21, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs , the Company's President and Chief Executive Officer, and Carmen Diersen , the
February 8, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced it will highlight a range of products and patient education programs at the American Academy of
January 27, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the three months and full year ended December 31, 2011
January 9, 2012 Preliminary Fourth Quarter Extremity Product Sales Expand by 17.5% AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists announced preliminary unaudited sales of $69.0
December 23, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs , the Company's President and Chief Executive Officer, and Carmen Diersen , the
November 8, 2011 Extremity Product Sales Growth Reported at 15%, 12% Constant Currency AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported sales of $57.6 million for the
AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its third quarter 2011 conference call will be held on Tuesday, November 8, 2011 at 5:30 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
August 9, 2011 Extremity Product Sales Growth Reported at 19%, 14% Constant Currency; Sales and Adjusted EBITDA Guidance Maintained for 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity
August 2, 2011 Simpliciti System Also Recently Launched in Europe at Prestigious Annecy Shoulder Course AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder,
July 13, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), announced today its second quarter 2011 conference call will be held on Tuesday, August 9, 2011 at 5:30 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
June 22, 2011 First Implant Performed in May by Sumant Krishnan, M.D AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot,
May 19, 2011 MINNEAPOLIS --(BUSINESS WIRE)-- Tornier Inc. the operating subsidiary of Tornier N.V. (NASDAQ: TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced
May 9, 2011 Sales Growth of 12% Drives Adjusted EBITDA Increase of 94% Company Raises Guidance for 2011 Sales and Adjusted EBITDA AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists,
May 9, 2011 Sales Growth of 12% Drives Adjusted EBITDA Increase of 94% Company Raises Guidance for 2011 Sales and Adjusted EBITDA AMSTERDAM--(BUSINESS WIRE)-- Insert "Consolidated Statements of Operations" table before "Condensed Consolidated Balance Sheets" table previously omitted by Business
AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its first quarter 2011 conference call will be held on Monday, May 9, 2011 at 5:00 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
April 14, 2011 BioFiber Expands Tornier Portfolio of Innovative Products for the Repair of Rotator Cuff and Other Tendon Injuries Tornier (NASDAQ: TRNX), a global leader in extremity orthopaedics, today announced the launch of its BioFiber ® Surgical Mesh for the repair of rotator cuff and other
March 7, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (the "Company") (Nasdaq: TRNX) announced today that the underwriters of its initial public offering exercised their option to purchase an additional 721,274 ordinary shares at a price of $19.00 per share (before underwriters' discounts and
March 1, 2011 Sales Growth of 13% in 2010 Drives Adjusted EBITDA Increase of 76% Extremity Product Lines Record 15% 2010 Growth AMSTERDAM, The Netherlands --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
February 15, 2011 EDINA, Minn. --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global leader in extremity orthopaedics, today announced it will highlight six new products at the American Academy of Orthopaedic Surgeons 2011 Annual Meeting ("AAOS") being held February 15-19 in San Diego, CA.
February 15, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its fourth quarter 2010 conference call will be held on Tuesday, March 1, 2011 at 5:00 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
February 2, 2011 AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (the “Company”) announced today the pricing of its initial public offering of 8,750,000 of the Company’s ordinary shares at a price to the public of $19.00 per share, all of which were offered by Tornier N.V.
